These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 12432233)

  • 1. Autocrine stimulation by insulin-like growth factor I is involved in the growth, tumorigenicity and chemoresistance of human esophageal carcinoma cells.
    Liu YC; Leu CM; Wong FH; Fong WS; Chen SC; Chang C; Hu CP
    J Biomed Sci; 2002; 9(6 Pt 2):665-74. PubMed ID: 12432233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of epidermal growth factor and insulin-like growth factor-I receptors and autocrine stimulation in human esophageal carcinoma cells.
    Chen SC; Chou CK; Wong FH; Chang CM; Hu CP
    Cancer Res; 1991 Apr; 51(7):1898-903. PubMed ID: 2004373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Id1-induced IGF-II and its autocrine/endocrine promotion of esophageal cancer progression and chemoresistance--implications for IGF-II and IGF-IR-targeted therapy.
    Li B; Tsao SW; Chan KW; Ludwig DL; Novosyadlyy R; Li YY; He QY; Cheung AL
    Clin Cancer Res; 2014 May; 20(10):2651-62. PubMed ID: 24599933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin-like growth factor 1 mediates 5-fluorouracil chemoresistance in esophageal carcinoma cells through increasing survivin stability.
    Juan HC; Tsai HT; Chang PH; Huang CY; Hu CP; Wong FH
    Apoptosis; 2011 Feb; 16(2):174-83. PubMed ID: 21082354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blockage of IGF-1R signaling sensitizes urinary bladder cancer cells to mitomycin-mediated cytotoxicity.
    Sun HZ; Wu SF; Tu ZH
    Cell Res; 2001 Jun; 11(2):107-15. PubMed ID: 11453542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An evaluation of the role of insulin-like growth factors (IGF) and of type-I IGF receptor signalling in hepatocarcinogenesis and in the resistance of hepatocarcinoma cells against drug-induced apoptosis.
    Alexia C; Fallot G; Lasfer M; Schweizer-Groyer G; Groyer A
    Biochem Pharmacol; 2004 Sep; 68(6):1003-15. PubMed ID: 15313394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth-inhibitory effects of human anti-insulin-like growth factor-I receptor antibody (A12) in an orthotopic nude mouse model of anaplastic thyroid carcinoma.
    Wang Z; Chakravarty G; Kim S; Yazici YD; Younes MN; Jasser SA; Santillan AA; Bucana CD; El-Naggar AK; Myers JN
    Clin Cancer Res; 2006 Aug; 12(15):4755-65. PubMed ID: 16899627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autocrine insulin-like growth factor-II stimulation of tumor cell migration is a progression step in human hepatocarcinogenesis.
    Nussbaum T; Samarin J; Ehemann V; Bissinger M; Ryschich E; Khamidjanov A; Yu X; Gretz N; Schirmacher P; Breuhahn K
    Hepatology; 2008 Jul; 48(1):146-56. PubMed ID: 18537183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth-regulatory mechanism of two human esophageal-cancer cell lines in protein-free conditions.
    Iihara K; Shiozaki H; Oku K; Tahara H; Doki Y; Oka H; Kadowaki T; Iwazawa T; Inoue M; Mori T
    Int J Cancer; 1993 Sep; 55(3):364-70. PubMed ID: 8375919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin-like growth factor I receptor blockade enhances chemotherapy and radiation responses and inhibits tumour growth in human gastric cancer xenografts.
    Min Y; Adachi Y; Yamamoto H; Imsumran A; Arimura Y; Endo T; Hinoda Y; Lee CT; Nadaf S; Carbone DP; Imai K
    Gut; 2005 May; 54(5):591-600. PubMed ID: 15831900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autocrine inhibition of chemotherapy response in human liver tumor cells by insulin-like growth factor-II.
    Lund P; Schubert D; Niketeghad F; Schirmacher P
    Cancer Lett; 2004 Mar; 206(1):85-96. PubMed ID: 15019164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo antitumor effects of the dual insulin-like growth factor-I/insulin receptor inhibitor, BMS-554417.
    Haluska P; Carboni JM; Loegering DA; Lee FY; Wittman M; Saulnier MG; Frennesson DB; Kalli KR; Conover CA; Attar RM; Kaufmann SH; Gottardis M; Erlichman C
    Cancer Res; 2006 Jan; 66(1):362-71. PubMed ID: 16397250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet-derived growth factor is an autocrine stimulator for the growth and survival of human esophageal carcinoma cell lines.
    Liu YC; Chen SC; Chang C; Leu CM; Hu CP
    Exp Cell Res; 1996 Nov; 228(2):206-11. PubMed ID: 8912712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A fully human monoclonal antibody to the insulin-like growth factor I receptor blocks ligand-dependent signaling and inhibits human tumor growth in vivo.
    Burtrum D; Zhu Z; Lu D; Anderson DM; Prewett M; Pereira DS; Bassi R; Abdullah R; Hooper AT; Koo H; Jimenez X; Johnson D; Apblett R; Kussie P; Bohlen P; Witte L; Hicklin DJ; Ludwig DL
    Cancer Res; 2003 Dec; 63(24):8912-21. PubMed ID: 14695208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin-like growth factor-I and human lung fibroblast-derived insulin-like growth factor-I stimulate the proliferation of human lung carcinoma cells in vitro.
    Ankrapp DP; Bevan DR
    Cancer Res; 1993 Jul; 53(14):3399-404. PubMed ID: 8391925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of type I interferons on IGF-mediated autocrine/paracrine growth of human neuroendocrine tumor cells.
    Vitale G; van Koetsveld PM; de Herder WW; van der Wansem K; Janssen JA; Colao A; Lombardi G; Lamberts SW; Hofland LJ
    Am J Physiol Endocrinol Metab; 2009 Mar; 296(3):E559-66. PubMed ID: 19141687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antitumor effects of an adenovirus expressing antisense insulin-like growth factor I receptor on human lung cancer cell lines.
    Lee CT; Wu S; Gabrilovich D; Chen H; Nadaf-Rahrov S; Ciernik IF; Carbone DP
    Cancer Res; 1996 Jul; 56(13):3038-41. PubMed ID: 8674059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting the insulin-like growth factor I receptor inhibits proliferation and VEGF production of non-small cell lung cancer cells and enhances paclitaxel-mediated anti-tumor effect.
    Spiliotaki M; Markomanolaki H; Mela M; Mavroudis D; Georgoulias V; Agelaki S
    Lung Cancer; 2011 Aug; 73(2):158-65. PubMed ID: 21190751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin-like growth factor-I decreased etoposide-induced apoptosis in glioma cells by increasing bcl-2 expression and decreasing CPP32 activity.
    Yin D; Tamaki N; Parent AD; Zhang JH
    Neurol Res; 2005 Jan; 27(1):27-35. PubMed ID: 15829155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting of insulin-like growth factor-I receptor with a monoclonal antibody inhibits growth of hepatic metastases from human colon carcinoma in mice.
    Bauer TW; Fan F; Liu W; Camp ER; Yang A; Somcio RJ; Bucana CD; Singh R; Ellis LM
    Ann Surg Oncol; 2007 Oct; 14(10):2838-46. PubMed ID: 17653802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.